Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emeline Dudognon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|June 7, 2014
Crystallization from the amorphous state: nucleation-growth decoupling, polymorphism interplay, and the role of interfacesMarc Descamps, Emeline Dudognon
Molecular Pharmaceutics|October 8, 2019
Molecular Mobility of Terfenadine: Investigation by Dielectric Relaxation Spectroscopy and Molecular Dynamics SimulationEmeline Dudognon, Jeanne-Annick Bama, Frédéric Affouard
The Journal of Physical Chemistry. B|September 30, 2021
Impact of Low Concentration of Strongly Hydrogen-Bonded Water Molecules on the Dynamics of Amorphous Terfenadine: Insights from Molecular Dynamics Simulations and Dielectric Relaxation SpectroscopyJeanne-Annick Bama, Emeline Dudognon, Frédéric Affouard
Polymers|May 14, 2025
Exploring the Relationship Between Stability and Dynamics in Polymer-Based Amorphous Solid Dispersions for Pharmaceutical ApplicationsEmeline Dudognon, Jeanne-Annick Bama, Frédéric Affouard
Pharmaceutical Research|August 11, 2012
Solid-solid transformation in racemic IbuprofenEmeline Dudognon, Natália T Correia, Florence Danède, et al.
Pharmaceutical Research|June 20, 2008
Evidence for a new crystalline phase of racemic IbuprofenEmeline Dudognon, Florence Danède, Marc Descamps, et al.
International Journal of Pharmaceutics|October 1, 2011
Raman spectroscopy of racemic ibuprofen: evidence of molecular disorder in phase IIAlain Hédoux, Yannick Guinet, Patrick Derollez, et al.
Molecular Pharmaceutics|December 21, 2012
A new protocol to determine the solubility of drugs into polymer matrixesAurélien Mahieu, Jean-François Willart, Emeline Dudognon, et al.
Acta Crystallographica. Section B, Structural Science|January 27, 2010
Ab initio structure determination of phase II of racemic ibuprofen by X-ray powder diffractionPatrick Derollez, Emeline Dudognon, Frédéric Affouard, et al.
International Journal of Pharmaceutics|December 29, 2015
Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in BiclotymolBenjamin Schammé, Nicolas Couvrat, Pascal Malpeli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|June 7, 2014
Crystallization from the amorphous state: nucleation-growth decoupling, polymorphism interplay, and the role of interfacesMarc Descamps, Emeline Dudognon
Molecular Pharmaceutics|October 8, 2019
Molecular Mobility of Terfenadine: Investigation by Dielectric Relaxation Spectroscopy and Molecular Dynamics SimulationEmeline Dudognon, Jeanne-Annick Bama, Frédéric Affouard
The Journal of Physical Chemistry. B|September 30, 2021
Impact of Low Concentration of Strongly Hydrogen-Bonded Water Molecules on the Dynamics of Amorphous Terfenadine: Insights from Molecular Dynamics Simulations and Dielectric Relaxation SpectroscopyJeanne-Annick Bama, Emeline Dudognon, Frédéric Affouard
Polymers|May 14, 2025
Exploring the Relationship Between Stability and Dynamics in Polymer-Based Amorphous Solid Dispersions for Pharmaceutical ApplicationsEmeline Dudognon, Jeanne-Annick Bama, Frédéric Affouard
Pharmaceutical Research|August 11, 2012
Solid-solid transformation in racemic IbuprofenEmeline Dudognon, Natália T Correia, Florence Danède, et al.
Pharmaceutical Research|June 20, 2008
Evidence for a new crystalline phase of racemic IbuprofenEmeline Dudognon, Florence Danède, Marc Descamps, et al.
International Journal of Pharmaceutics|October 1, 2011
Raman spectroscopy of racemic ibuprofen: evidence of molecular disorder in phase IIAlain Hédoux, Yannick Guinet, Patrick Derollez, et al.
Molecular Pharmaceutics|December 21, 2012
A new protocol to determine the solubility of drugs into polymer matrixesAurélien Mahieu, Jean-François Willart, Emeline Dudognon, et al.
Acta Crystallographica. Section B, Structural Science|January 27, 2010
Ab initio structure determination of phase II of racemic ibuprofen by X-ray powder diffractionPatrick Derollez, Emeline Dudognon, Frédéric Affouard, et al.
International Journal of Pharmaceutics|December 29, 2015
Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in BiclotymolBenjamin Schammé, Nicolas Couvrat, Pascal Malpeli, et al.
Pageof 2